WASATCH ADVISORS LP – Kymera Therapeutics, Inc. Transaction History
WASATCH ADVISORS LP portfolio value:
$23.08M
portfolio value
WASATCH ADVISORS LP quarter portfolio value change:
+10.56%
quarter
Kymera Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +85.85% | 489.91K shares | 11.85M | $21.77 | 1.06M |
| Q2 2022 | share | Increase | +140.42% | 333.28K shares | 1.19M | $19.69 | 570.64K |
| Q1 2022 | share | Decrease | -1.49% | -3.59K shares | -5.25M | $42.32 | 237.35K |
| Q4 2021 | share | Decrease | -0.17% | -415 shares | 1.12M | $62.98 | 240.95K |
| Q3 2021 | share | Increase | +0.95% | 2.26K shares | 2.58M | $58.74 | 241.36K |
| Q2 2021 | share | Increase | 0.00% | 239.10K shares | 11.59M | $48.5 | 239.10K |